Nexien Biopharma, Inc.
NXEN
Revenue
0.00
0.000.00%
3 Months ChangeAssets
4.18k
▼-10.08k▼-70.68%
3 Months ChangeLiabilities
365.43k
▲25.87k▲7.62%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-15
Form 10-Q
ID: 0001493152-24-019400
2024-02-20
Form 10-Q
ID: 0001493152-24-007096
2023-11-14
Form 10-Q
ID: 0001493152-23-041255
2023-05-17
Form 10-Q
ID: 0001493152-23-017925
2023-02-08
Form 10-Q
ID: 0001493152-23-003903
2022-11-09
Form 10-Q
ID: 0001493152-22-031033
2022-05-12
Form 10-Q
ID: 0001493152-22-012957
2022-02-08
Form 10-Q
ID: 0001493152-22-003407
2022-01-21
Form 8-K
ID: 0001493152-22-001830
2021-11-22
Form 10-Q
ID: 0001493152-21-029479